204 related articles for article (PubMed ID: 35884897)
1. Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure.
Muthuramu I; Mishra M; De Geest B
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884897
[TBL] [Abstract][Full Text] [Related]
2. Distinct Phenotypes Induced by Different Degrees of Transverse Aortic Constriction in C57BL/6N Mice.
Deng H; Ma LL; Kong FJ; Qiao Z
Front Cardiovasc Med; 2021; 8():641272. PubMed ID: 33969009
[TBL] [Abstract][Full Text] [Related]
3. Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains.
Zi M; Stafford N; Prehar S; Baudoin F; Oceandy D; Wang X; Bui T; Shaheen M; Neyses L; Cartwright EJ
Curr Res Physiol; 2019 Dec; 1():1-10. PubMed ID: 32699840
[TBL] [Abstract][Full Text] [Related]
4. Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload.
Amin R; Muthuramu I; Aboumsallem JP; Mishra M; Jacobs F; De Geest B
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930153
[TBL] [Abstract][Full Text] [Related]
5. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
[TBL] [Abstract][Full Text] [Related]
6. A time-series minimally invasive transverse aortic constriction mouse model for pressure overload-induced cardiac remodeling and heart failure.
Wang X; Zhu X; Shi L; Wang J; Xu Q; Yu B; Qu A
Front Cardiovasc Med; 2023; 10():1110032. PubMed ID: 36891245
[TBL] [Abstract][Full Text] [Related]
7. Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.
Heron C; Dumesnil A; Houssari M; Renet S; Lemarcis T; Lebon A; Godefroy D; Schapman D; Henri O; Riou G; Nicol L; Henry JP; Valet M; Pieronne-Deperrois M; Ouvrard-Pascaud A; Hagerling R; Chiavelli H; Michel JB; Mulder P; Fraineau S; Richard V; Tardif V; Brakenhielm E
Cardiovasc Res; 2023 Mar; 119(2):492-505. PubMed ID: 35689481
[TBL] [Abstract][Full Text] [Related]
8. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
[TBL] [Abstract][Full Text] [Related]
9. Differential mRNA Expression and Circular RNA-Based Competitive Endogenous RNA Networks in the Three Stages of Heart Failure in Transverse Aortic Constriction Mice.
Li X; Tan W; Zheng S; Pyle WG; Zhu C; Chen H; Kang L; Wu J; Zou Y; Backx PH; Yang FH
Front Physiol; 2022; 13():777284. PubMed ID: 35330931
[TBL] [Abstract][Full Text] [Related]
10. [The Observation of Liver and Kidney Injury and the Activation of Macrophages in the Overload Pressure Induced Cardiac Hypertrophy/Heart Failure Mouse Model].
Quan Y; Tian GE; Zhou JT; Wu WC; Liu XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):331-336. PubMed ID: 32543138
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin 1 aggravates hypertrophic heart failure caused by pressure overload via shifting energy metabolism.
Van Le TN; Zoungrana LI; Wang H; Fatmi MK; Ren D; Krause-Hauch M; Li J
Biochem Biophys Res Commun; 2022 Dec; 637():170-180. PubMed ID: 36403480
[TBL] [Abstract][Full Text] [Related]
13. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
14. Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice.
Tannu S; Allocco J; Yarde M; Wong P; Ma X
J Pharmacol Toxicol Methods; 2020; 106():106935. PubMed ID: 33096237
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
[TBL] [Abstract][Full Text] [Related]
16. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
[TBL] [Abstract][Full Text] [Related]
17. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.
Izumiya Y; Shiojima I; Sato K; Sawyer DB; Colucci WS; Walsh K
Hypertension; 2006 May; 47(5):887-93. PubMed ID: 16567591
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.
Yu Y; Hu Z; Li B; Wang Z; Chen S
Mol Cell Biochem; 2019 Jan; 450(1-2):25-34. PubMed ID: 29790114
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
